Vnitr Lek 2016, 62(1):5-6

Moudře a pomalu - editorial

Jiří Vítovec
I. interní kardioangiologická klinika LF MU a FN u sv. Anny, Brno

Received: September 20, 2015; Published: January 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vítovec J. Moudře a pomalu - editorial. Vnitr Lek. 2016;62(1):5-6.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. McMurray JJ, Adamopoulos S, Anker SD et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Europ Heart J 2012; 33(14): 1787-1847. Erratum in Eur Heart J 2013; 34(2): 158. Go to original source... Go to PubMed...
    2. ©pinar J, Vítovec J, Hradec J et al. Czech Society of Cardiology guidelines for the diagnosis and treatment of chronic heart failure 2011. Cor Vasa 2012; 54(2): e113-e134. Dostupné z DOI: <http://dx.doi.org/10.1016/j.crvasa.2012.03.002>. Go to original source...
    3. Dúbrava J. Prieskum "3P (Pacient - Pulz - Prognóza) pri srdcovom zlyhávaní" so zameraním na srdcovú frekvenciu. Vnitř Lék 2016; 62(1): 17-24.
    4. Takahama H, Yokoyama H, Kada A et al. Extent of heart rate reduction during hospitalization using beta-blockers, not the achieved heart rate itself at discharge, predicts the clinical outcome in patients with acute heart failure syndromes. J Cardiol 2013; 61(1): 58-64. Go to original source... Go to PubMed...
    5. Swedberg K, Komajda M, Böhm M et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 2010; 376(9744): 875-885. Go to original source... Go to PubMed...
    6. Böhm M, Swedberg K, Komajda M. On behalf of the SHIFT Investigators. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 2010; 376(9744): 886-894. Go to original source... Go to PubMed...
    7. Zugck C, Martinka P, Stöckl G. Ivabradine treatment in a chronic heart failure patient cohort: symptom reduction and improvement in quality of life in clinical practice. Adv Ther 2014; 31(9): 961-974. Go to original source... Go to PubMed...
    8. Hradec J. Jak optimalizovat léčbu chronického srdečního selhání farmakologickou modulací srdeční frekvence. Remedia 2013; 23(2): 90-96.
    9. Bultas J. Ivabradin. Remedia 2006; 16(5): 463-473.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.